Share this e-Alert:

Polsinelli - Health Care Litigation Polsinelli - Health Care Litigation


May 2015


Judge Endorses Extrapolation Techniques for False Claims Act Whistleblowers






Law Firm of the Year - U.S. News and World Report - Health Care Law - 2015

For more information about this e-Alert, please contact:


Mary Clare Bonaccorsi

Practice Area Chair



Email | Bio


Additional Health Care Litigation Leaders:


Sherri T. Alexander

Practice Area Vice Chair


Email | Bio


To learn more about our Health Care Litigation practice, to contact one of our Health Care Litigation attorneys, or for more Health Care Litigation Intelligence, click here.


View Polsinelli documents on JD Supra  


LinkedIn Twitter Facebook Inside Law Podcast Connect with us on LinkedIn. Connection with us on Twitter. Connect with us on Facebook.

In a lawsuit brought under the False Claims Act ("FCA") a federal district judge in Florida recently rejected a defendant's challenge to a statistical sampling and extrapolation methodology advanced by a qui tam plaintiff's expert witness in order to avoid offering into evidence each and every one of the allegedly false claims that were at issue in the case. In the court's opinion, Judge Steven D. Merryday recognized that "no universal ban on expert testimony based on statistical sampling applies in a qui tam action." The key takeaway for providers is the potential for expanded FCA liability, because courts may permit plaintiffs to use a sampling of claims – as opposed to the entire universe of claims at issue – in order to meet their burden of proof.

Case Summary

The qui tam plaintiff/relator, brought claims under the FCA and the Florida False Claims Act, alleging that his former employer, a nursing and rehabilitation center, "flagrantly upcoded" and "upcharged" for services at 53 Florida facilities. Because the evidence supporting the claims submitted by those 53 facilities was so voluminous, the qui tam plaintiff/relator sought to avoid a claim by claim approach and, instead, offered expert testimony based on a sampling of claims from which it would extrapolate the total amount of claims that were allegedly overpaid by Medicare and Medicaid.

The defendants argued that the expert testimony was inadmissible and that statistical sampling is impermissible in a FCA lawsuit. The court held that no such ban on this sort of evidence exists in FCA cases -- but stated that other defects in the expert's methods could result in exclusion, indicating that a Daubert hearing would best resolve any such issues/defects.

Last week's decision is not the first time that a court has permitted the use of statistical sampling as evidence in an FCA case. In fact, the court relied heavily upon a 2014 federal court decision in Tennessee, United States ex. Rel. Martin v. Life Care Centers of America, Inc. 2014 BL 276533 (E.D. Tenn. Sept. 29 2014), in which the court allowed the plaintiff's sampling and extrapolation methodology, and held that limiting the use of statistical sampling would restrict the effectiveness of the FCA to combat fraud.


At the onset of any FCA case, providers should be aware of the trend in federal FCA actions in which qui tam plaintiffs may have leverage in utilizing extrapolation techniques to prove FCA liability. Providers should begin to arm themselves with facts, as well as their own statistical experts, who can undermine the validity and reliability of the sampling approach and disqualify through a Daubert hearing a qui tam relator's expert witness. Polsinelli's experience in advising and defending health care clients in FCA matters is significant as qui tam plaintiffs' tactics continue to evolve -- and as courts across the country address those evolving tactics.

For More Information

For questions regarding the content of this alert, please contact:














Atlanta  Chattanooga  Chicago  Dallas  Denver  Edwardsville  Jefferson City  Kansas City  Los Angeles  Nashville  New York
Overland Park  Phoenix  Raleigh  St. Joseph  St. Louis  San Francisco  Springfield  Topeka  Washington, D.C.  Wilmington








real challenges. real answers.SM  
Polsinelli is a first generation Am Law 100 firm serving corporations, institutions, entrepreneurs and individuals nationally. Our attorneys successfully build enduring client relationships by providing practical legal counsel infused with business insight, and with a passion for assisting General Counsel and CEOs in achieving their objectives. Polsinelli is ranked 18th in number of U.S. partners* and has more than 740 attorneys in 21 offices. Profiled by The American Lawyer and ranked as the fastest growing U.S. law firm over a six-year period**, the firm focuses on healthcare, financial services, real estate, life sciences and technology, energy and business litigation, and has depth of experience in 100 service areas and 70 industries. The firm can be found online at Polsinelli PC. In California, Polsinelli LLP.

* Law360, March 2014
** The American Lawyer 2013 and 2014 reports







Polsinelli provides this material for informational purposes only. The material provided herein is general and is not intended to be legal advice. Polsinelli is very proud of the results we obtain for our clients, but you should know that past results do not guarantee future results; that every case is different and must be judged on its own merits; and that the choice of a lawyer is an important decision and should not be based solely upon advertisements.

Copyright © 2015 Polsinelli PC.

Connect with us on LinkedIn. Connection with us on Twitter. Connect with us on Facebook. Polsinelli Health Care Health Care